In vitro evaluation of the growth inhibition and apoptosis effect of mifepristone (RU486) in human Ishikawa and HEC1A endometrial cancer cell lines

被引：0

作者：

Marisa A. Navo

Judith A. Smith

Anjali Gaikwad

Thomas Burke

Jubilee Brown

Lois M. Ramondetta

机构：

[1] The University of Texas,Division of Pharmacy

[2] M. D. Anderson Cancer Center,Department of Gynecologic Oncology, Division of Surgery

[3] The University of Texas,Department of Obstetrics and Gynecology

[4] M. D. Anderson Cancer Center,undefined

[5] University of Texas Health Sciences Center at Houston Medical School,undefined

来源：

Cancer Chemotherapy and Pharmacology | 2008年 / 62卷

关键词：

RU486; Mifepristone; Progesterone; Endometrial; Cancer; Estrogen receptor;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：483 / 489

页数：6

共 106 条

[1]

Jemal A(2007)Cancer statistics, 2006 CA Cancer J Clin 57 43-66

[2]

Siegel R(2004)Focus on endometrial and cervical cancer Cancer Cell 5 533-538

[3]

Ward E(2002)Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review Cancer Epidemiol Biomarkers Prev 11 1531-1543

[4]

Ellenson LH(2005)Polycystic ovary syndrome and gynecological cancers: is there a link? Gynecol Endocrinol 20 200-208

[5]

Wu TC(2003)Progesterone antagonists and progesterone receptor modulators: an overview Steroids 68 981-993

[6]

Kaaks R(1998)Mechanism of action and clinical effects of antiprogestins on the non-pregnant uterus Hum Reprod Update 4 584-593

[7]

Lukanova A(2004)Systematic review of mifepristone for the treatment of uterine leiomyomata Obstet Gynecol 103 1331-1336

[8]

Kurzer MS(2006)Effect of mifepristone for symptomatic leiomyomata on quality of life and uterine size Obstet Gynecol 108 1381-1387

[9]

Gadducci A(1997)Mifepristone (RU486): a review Fertil Steril 68 967-976

[10]

Gargini A(2003)Low-dose mifepristone for uterine leiomyomata Obstet Gynecol 101 243-250